ARAY
Price
$1.51
Change
-$0.00 (-0.00%)
Updated
Sep 5, 01:52 PM (EDT)
Capitalization
170.14M
54 days until earnings call
BNGO
Price
$3.85
Change
+$0.21 (+5.77%)
Updated
Sep 5, 01:44 PM (EDT)
Capitalization
17.04M
Interact to see
Advertisement

ARAY vs BNGO

Header iconARAY vs BNGO Comparison
Open Charts ARAY vs BNGOBanner chart's image
Accuray
Price$1.51
Change-$0.00 (-0.00%)
Volume$5K
Capitalization170.14M
Bionano Genomics
Price$3.85
Change+$0.21 (+5.77%)
Volume$101
Capitalization17.04M
ARAY vs BNGO Comparison Chart in %
Loading...
ARAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BNGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARAY vs. BNGO commentary
Sep 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARAY is a StrongBuy and BNGO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 05, 2025
Stock price -- (ARAY: $1.51 vs. BNGO: $3.64)
Brand notoriety: ARAY and BNGO are both not notable
ARAY represents the Medical/Nursing Services, while BNGO is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ARAY: 65% vs. BNGO: 129%
Market capitalization -- ARAY: $170.14M vs. BNGO: $17.04M
ARAY [@Medical/Nursing Services] is valued at $170.14M. BNGO’s [@Pharmaceuticals: Other] market capitalization is $17.04M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $231.15B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $162.93B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.63B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.95B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARAY’s FA Score shows that 0 FA rating(s) are green whileBNGO’s FA Score has 0 green FA rating(s).

  • ARAY’s FA Score: 0 green, 5 red.
  • BNGO’s FA Score: 0 green, 5 red.
According to our system of comparison, both ARAY and BNGO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARAY’s TA Score shows that 5 TA indicator(s) are bullish while BNGO’s TA Score has 5 bullish TA indicator(s).

  • ARAY’s TA Score: 5 bullish, 5 bearish.
  • BNGO’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both ARAY and BNGO are a good buy in the short-term.

Price Growth

ARAY (@Medical/Nursing Services) experienced а -3.21% price change this week, while BNGO (@Pharmaceuticals: Other) price change was -5.45% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.15%. For the same industry, the average monthly price growth was +4.26%, and the average quarterly price growth was +24.89%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.57%. For the same industry, the average monthly price growth was +6.79%, and the average quarterly price growth was +18.37%.

Reported Earning Dates

ARAY is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Medical/Nursing Services (-0.15% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (-1.57% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARAY($170M) has a higher market cap than BNGO($17M). ARAY YTD gains are higher at: -23.737 vs. BNGO (-78.964). ARAY has higher annual earnings (EBITDA): 20.6M vs. BNGO (-60.99M). ARAY has more cash in the bank: 77.8M vs. BNGO (16.4M). BNGO has less debt than ARAY: BNGO (19.6M) vs ARAY (214M). ARAY has higher revenues than BNGO: ARAY (465M) vs BNGO (27.4M).
ARAYBNGOARAY / BNGO
Capitalization170M17M1,000%
EBITDA20.6M-60.99M-34%
Gain YTD-23.737-78.96430%
P/E RatioN/A0.03-
Revenue465M27.4M1,697%
Total Cash77.8M16.4M474%
Total Debt214M19.6M1,092%
FUNDAMENTALS RATINGS
ARAY vs BNGO: Fundamental Ratings
ARAY
BNGO
OUTLOOK RATING
1..100
7670
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
41
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9199
PRICE GROWTH RATING
1..100
6156
P/E GROWTH RATING
1..100
4290
SEASONALITY SCORE
1..100
3650

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BNGO's Valuation (41) in the Biotechnology industry is somewhat better than the same rating for ARAY (85) in the Medical Specialties industry. This means that BNGO’s stock grew somewhat faster than ARAY’s over the last 12 months.

BNGO's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ARAY (100) in the Medical Specialties industry. This means that BNGO’s stock grew similarly to ARAY’s over the last 12 months.

ARAY's SMR Rating (91) in the Medical Specialties industry is in the same range as BNGO (99) in the Biotechnology industry. This means that ARAY’s stock grew similarly to BNGO’s over the last 12 months.

BNGO's Price Growth Rating (56) in the Biotechnology industry is in the same range as ARAY (61) in the Medical Specialties industry. This means that BNGO’s stock grew similarly to ARAY’s over the last 12 months.

ARAY's P/E Growth Rating (42) in the Medical Specialties industry is somewhat better than the same rating for BNGO (90) in the Biotechnology industry. This means that ARAY’s stock grew somewhat faster than BNGO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARAYBNGO
RSI
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
73%
Advances
ODDS (%)
Bullish Trend 15 days ago
76%
Bullish Trend 16 days ago
77%
Declines
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ARAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BNGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SHIP8.250.40
+5.10%
Seanergy Maritime Holdings Corp
GEHC74.121.74
+2.40%
GE HealthCare Technologies
PSFE13.450.08
+0.60%
Paysafe Limited
FRSH13.01-0.08
-0.61%
Freshworks
INTJ0.59-0.11
-16.00%
Intelligent Group Limited

ARAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARAY has been loosely correlated with ILMN. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ARAY jumps, then ILMN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARAY
1D Price
Change %
ARAY100%
+3.42%
ILMN - ARAY
42%
Loosely correlated
+1.68%
NVST - ARAY
41%
Loosely correlated
+2.36%
A - ARAY
41%
Loosely correlated
+2.60%
TWST - ARAY
40%
Loosely correlated
-1.42%
GKOS - ARAY
40%
Loosely correlated
-4.58%
More

BNGO and

Correlation & Price change

A.I.dvisor tells us that BNGO and MBOT have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BNGO and MBOT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BNGO
1D Price
Change %
BNGO100%
-6.19%
MBOT - BNGO
33%
Poorly correlated
-4.80%
MDT - BNGO
30%
Poorly correlated
+0.65%
ARAY - BNGO
29%
Poorly correlated
+3.42%
LMAT - BNGO
29%
Poorly correlated
+2.65%
NEOG - BNGO
28%
Poorly correlated
+0.35%
More